Thousand Oaks, CA, United States of America

Zhe Huang


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Thousand Oaks, CA (US) (2022)
  • Action, MA (US) (2024)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zhe Huang - Innovator in Anti-Sclerostin Antibody Research

Introduction

Zhe Huang is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-sclerostin antibodies. With a total of 2 patents, his work is paving the way for advancements in therapeutic applications.

Latest Patents

Zhe Huang's latest patents include innovative approaches to anti-sclerostin antibodies. The first patent focuses on C-terminal anti-sclerostin antibody variants, which generally relate to antibodies having C-terminal modifications and the compositions that comprise such antibodies. The second patent also addresses C-terminal antibody variants, emphasizing the same modifications and their potential applications.

Career Highlights

Zhe Huang is currently employed at Amgen Inc., a leading biotechnology company known for its commitment to innovative therapies. His work at Amgen has allowed him to explore and develop groundbreaking solutions in the field of antibody research.

Collaborations

Zhe Huang collaborates with talented professionals, including Jennitte LeAnn Stevens and Greg Flynn. These partnerships enhance the research and development efforts at Amgen, contributing to the advancement of biotechnology.

Conclusion

Zhe Huang's contributions to the field of anti-sclerostin antibodies demonstrate his commitment to innovation and research. His patents and work at Amgen highlight the importance of collaboration in driving advancements in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…